<DOC>
	<DOCNO>NCT02332577</DOCNO>
	<brief_summary>Primary Objective : To evaluate clinical efficacy pristinamycin dose 2g x 2/day 2 day 1g x 3/day 5 7 day versus amoxicillin 1g x3 /day 7 9 day , 5 9 day end treatment . Secondary Objectives : To evaluate clinical efficacy subpopulation bacteriologically document inclusion accord procalcitonin level . To evaluate efficacy treatment pneumococcus . To evaluate rate relapse mortality 30±2 day treatment start . To document failure . To collect follow adverse event .</brief_summary>
	<brief_title>Study Compare Efficacy Pristinamycin ( Pyostacine ® ) Versus Amoxicillin Treatment Acute Community Acquired Pneumonia</brief_title>
	<detailed_description>The total study duration patient 1 month treatment period 7 9 day follow-up period 21 23 day .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<mesh_term>Pristinamycin</mesh_term>
	<criteria>Inclusion criterion : Male female 18 year old presumed bacterial acute community acquire pneumonia present PORT score II III ( Fine II III ) . The acute community acquire pneumonia define : Pulmonary xray ( carry within 48 hour prior randomization ) show new lobar multilobar infiltrates . At least 4 functional and/or clinical symptom among follow : Fever characterize temperature 38.5 least within 24h prior inclusion . Appearance aggravation cough . Appearance purulent expectoration . Appearance aggravation dyspnoea . Tachypnoea Chest pain A characteristic sign percussion and/or auscultation associate pulmonary condensation focus . Exclusion criterion : Patients diagnose legionellosis . Patients receive systemic antibiotic therapy 24 hour within week precede start study treatment . Associated neoplasm ( active cancer [ whatever type , solid haematological ] diagnose within year basocellular skin cancer ) . Severe severe chronic obstructive pulmonary disease ( COPD ) ( GOLD3 GOLD4 ) . History bacterial pneumonia past 12 month . Bronchopulmonary diseases likely interfere assessment therapeutic response . Known hypersensitivity streptogramins , penicillin betalactamines excipients treatment study . History severe skin reaction take pristinamycin amoxicillin . Kidney disease ( chronic kidney failure creatinine clearance ≤30 mL/minute ) . Patients treat allopurinol , colchicine , immunosuppressant ( cyclosporin , tacrolimus , mycophenolate mofetil , methotrexate , biotherapies ) oral anticoagulant previous 6 month study . Known HIV infection , whatever stage . The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>